✦ LIBER ✦

Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease

✍ Scribed by S. Argüelles; J.L. Venero; S. García-Rodriguez; M. Tomas-Camardiel; A. Ayala; J. Cano; A. Machado

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers for the diagnosis and managem

✍ Waragai, Masaaki; Sekiyama, Kazunari; Fujita, Masayo; Tokuda, Takahiko; Hashimot 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 584 KB

Potential role of uric acid as a biomark

✍ Yi-Xian Huang; Wei-Feng Luo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 35 KB

3.128 Cardiac metaiodobenzylguanidine sc

✍ H. Sawada; T. Oeda; K. Yamamoto; N. Murase; E. Mizuta; K. Yamakawa; H. Takeuchi; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P3.130 Serum proteomic biomarkers for th

✍ K. Markopoulou; J. Bryson; B. Chase; S. Quintero; E. Sheta; M. Sabbagh; I. Goldk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Transthyretin as a potential CSF biomark

✍ K. Schultz; K. Nilsson; J. E. Nielsen; S. G. Lindquist; L. E. Hjermind; B. B. An 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The potential of GDNF as a treatment for

✍ Carrie B. Hurelbrink; Roger A. Barker 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 109 KB